Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Molokhia

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Pharmaceutical Sciences|August 1, 1977
Dissolution rates of model gallstones in human and animal biles and importance of interfacial resistanceA M Molokhia, A F Hofmann, W I Higuchi, et al.
Human Genetics|January 25, 2003
Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean populationM Molokhia, C Hoggart, A L Patrick, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2012
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient studyV E Valkhoff, E M van Soest, G M C Masclee, et al.
Clinical Pharmacology and Therapeutics|May 13, 2011
Phenotype standardization for immune-mediated drug-induced skin injuryM Pirmohamed, P S Friedmann, M Molokhia, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Journal of Public Health (Oxford, England)|May 31, 2022
Developing and testing a case-management intervention to support the return to work of health care workers with common mental health disordersV Parsons, D Juszczyk, G Gilworth, et al.
Diabetes, Obesity & Metabolism|December 21, 2007
Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetesJ-F Louet, S B Smith, J-F Gautier, et al.
The Pharmacogenomics Journal|January 12, 2011
Genome-wide association study of serious blistering skin rash caused by drugsY Shen, P Nicoletti, A Floratos, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?G M C Masclee, V E Valkhoff, E M van Soest, et al.
Gut|November 7, 2008
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancyP H Dixon, S W C van Mil, J Chambers, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical Sciences|August 1, 1977
Dissolution rates of model gallstones in human and animal biles and importance of interfacial resistanceA M Molokhia, A F Hofmann, W I Higuchi, et al.
Human Genetics|January 25, 2003
Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean populationM Molokhia, C Hoggart, A L Patrick, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2012
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient studyV E Valkhoff, E M van Soest, G M C Masclee, et al.
Clinical Pharmacology and Therapeutics|May 13, 2011
Phenotype standardization for immune-mediated drug-induced skin injuryM Pirmohamed, P S Friedmann, M Molokhia, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Journal of Public Health (Oxford, England)|May 31, 2022
Developing and testing a case-management intervention to support the return to work of health care workers with common mental health disordersV Parsons, D Juszczyk, G Gilworth, et al.
Diabetes, Obesity & Metabolism|December 21, 2007
Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetesJ-F Louet, S B Smith, J-F Gautier, et al.
The Pharmacogenomics Journal|January 12, 2011
Genome-wide association study of serious blistering skin rash caused by drugsY Shen, P Nicoletti, A Floratos, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?G M C Masclee, V E Valkhoff, E M van Soest, et al.
Gut|November 7, 2008
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancyP H Dixon, S W C van Mil, J Chambers, et al.
Pageof 6